The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Phencyclidine animal models of schizophrenia: Approaches from abnormality of glutamatergic neurotransmission and neurodevelopment
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Neurobiology of Pavlovian fear conditioning
Maren, S. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.897 · Cited by 1,543
Geyer, M. A., Krebs-Thomson, K., Braff, D. L., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100811 · Cited by 1,484
Medial Frontal Cortex Mediates Perceptual Attentional Set Shifting in the Rat
Birrell, J. M., & Brown, V. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04320.2000 · Cited by 1,421
Jentsch, J. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00060-8 · Cited by 1,314
Pathological Changes Induced in Cerebrocortical Neurons by Phencyclidine and Related Drugs
Olney, J. W., Labruyere, J., & Price, M. T. (1989) · Science · doi:10.1126/science.2660263 · Cited by 1,237
Translating developmental time across mammalian species
Clancy, B., Darlington, R. B., & Finlay, B. L. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00171-3 · Cited by 1,221
Prestimulus Effects on Human Startle Reflex in Normals and Schizophrenics
Braff, D., Stone, C., Callaway, E., Geyer, M., Glick, I., & Bali, L. (1978) · Psychophysiology · doi:10.1111/j.1469-8986.1978.tb01390.x · Cited by 1,170
Schizophrenia as a Disorder of Neurodevelopment
Lewis, D. A., & Levitt, P. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142754 · Cited by 1,163
Nuechterlein, K. H., & Dawson, M. E. (1984) · Schizophrenia Bulletin · doi:10.1093/schbul/10.2.160 · Cited by 1,140
Modulation of Neuronal Migration by NMDA Receptors
Komuro, H., & Rakic, P. (1993) · Science · doi:10.1126/science.8096653 · Cited by 1,041
Schizophrenics Show Spatial Working Memory Deficits
Park, S. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820120063009 · Cited by 945
Hashimoto, T., Volk, D. W., Eggan, S. M., Mirnics, K., Pierri, J. N., Sun, Z., Sampson, A. R., & Lewis, D. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06315.2003 · Cited by 938
Study of a New Schizophrenomimetic Drug—Sernyl
LUBY, E. D. (1959) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1959.02340150095011 · Cited by 921
Impulse activity and the patterning of connections during cns development
Shatz, C. J. (1990) · Neuron · doi:10.1016/0896-6273(90)90333-b · Cited by 766
Size of burden of schizophrenia and psychotic disorders
Rössler, W., Joachim Salize, H., van Os, J., & Riecher-Rössler, A. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.04.009 · Cited by 741
To Model a Psychiatric Disorder in Animals Schizophrenia As a Reality Test
Lipska, B. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00137-8 · Cited by 650
Phencyclidine-induced psychosis
(1978) · American Journal of Psychiatry · doi:10.1176/ajp.135.9.1081 · Cited by 478
Akbarian, S., Sucher, N., Bradley, D., Tafazzoli, A., Trinh, D., Hetrick, W., Potkin, S., Sandman, C., Bunney, W., & Jones, E. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-01-00019.1996 · Cited by 441
Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics
BEASLEY, C., & REYNOLDS, G. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(96)00122-3 · Cited by 426
Jentsch, J. D., Redmond, D. E., Elsworth, J. D., Taylor, J. R., Youngren, K. D., & Roth, R. H. (1997) · Science · doi:10.1126/science.277.5328.953 · Cited by 398
Negative Symptoms and Hypofrontality in Chronic Schizophrenia
Wolkin, A. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820120047007 · Cited by 393
Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response.
Bakshi, V. P., Swerdlow, N. R., & Geyer, M. A. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23831-9 · Cited by 329
Rosenheck, R. (2003) · JAMA · doi:10.1001/jama.290.20.2693 · Cited by 326
Jentsch, J. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00034-1 · Cited by 320
Synaptic activation of NF-kappa B by glutamate in cerebellar granule neurons in vitro.
Guerrini, L., Blasi, F., & Denis-Donini, S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9077 · Cited by 287
Modulation of NMDA receptor function: implications for vertebrate neural development
Scheetz, A. J., & Constantine‐Paton, M. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.10.8050674 · Cited by 285
Neuropsychological evidence for frontostriatal dysfunction in schizophrenia
Elliott, R., McKenna, P. J., Robbins, T. W., & Sahakian, B. J. (1995) · Psychological Medicine · doi:10.1017/s0033291700033523 · Cited by 267
Schizophrenia and the frontal lobe
WEINBERGER, D. (1988) · Trends in Neurosciences · doi:10.1016/0166-2236(88)90060-4 · Cited by 262
Sams-Dodd, F. (1996) · Behavioural Pharmacology · doi:10.1097/00008877-199601000-00001 · Cited by 247
David Sturgeon, R., Fessler, R. G., & Meltzer, H. Y. (1979) · European Journal of Pharmacology · doi:10.1016/0014-2999(79)90279-6 · Cited by 239
Cochran, S. M., Kennedy, M., McKerchar, C. E., Steward, L. J., Pratt, J. A., & Morris, B. J. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300031 · Cited by 236
Wang, C., McInnis, J., Ross-Sanchez, M., Shinnick-Gallagher, P., Wiley, J. L., & Johnson, K. M. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00384-0 · Cited by 234
Noda, Y., Yamada, K., Furukawa, H., & Nabeshima, T. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb15106.x · Cited by 224
Self-citationDepoortère, R., Dargazanli, G., Estenne-Bouhtou, G., Coste, A., Lanneau, C., Desvignes, C., Poncelet, M., Heaulme, M., Santucci, V., Decobert, M., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300772 · Cited by 220
Abdul-Monim, Z., Neill, J. C., & Reynolds, G. P. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881107067097 · Cited by 206
Yamamoto, B., & Cooperman, M. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-07-04159.1994 · Cited by 203
PDE10A inhibition reverses subchronic PCP‐induced deficits in attentional set‐shifting in rats
Rodefer, J. S., Murphy, E. R., & Baxter, M. G. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03937.x · Cited by 199
The Role of Glutamate Transporters in Glutamate Homeostasis in the Brain
Takahashi, M., Billups, B., Rossi, D., Sarantis, M., Hamann, M., & Attwell, D. (1997) · Journal of Experimental Biology · doi:10.1242/jeb.200.2.401 · Cited by 194
Dracheva, S., Marras, S. A. E., Elhakem, S. L., Kramer, F. R., Davis, K. L., & Haroutunian, V. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.9.1400 · Cited by 190
Bakshi, V. P., & Geyer, M. A. (1995) · Psychopharmacology · doi:10.1007/bf02246096 · Cited by 189
Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implications
Carlsson, A., Hansson, L. O., Waters, N., & Carlsson, M. L. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00228-2 · Cited by 187
Keith, V. A., Mansbach, R. S., & Geyer, M. A. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90025-h · Cited by 186
Reynolds, G. P., Abdul-Monim, Z., Neill, J. C., & Zhang, Z. (2004) · Neurotoxicity Research · doi:10.1007/bf03033297 · Cited by 171
Egerton, A., Reid, L., McKerchar, C. E., MORRIS, B. J., & Pratt, J. A. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2109-y · Cited by 166
Distinct effects of d-amphetamine and phencyclidine on the social behaviour of rats
Sams‐Dodd, F. (1995) · Behavioural Pharmacology · doi:10.1097/00008877-199501000-00009 · Cited by 164
Jentsch, J. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00004-9 · Cited by 164
Hashimoto, K., Fujita, Y., Shimizu, E., & Iyo, M. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.07.002 · Cited by 159
Abdul-Monim, Z., Reynolds, G. P., & Neill, J. C. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.01.019 · Cited by 157
Schizophrenia as a developmental disorder of the cerebral cortex
Raedler, T. J., Knable, M. B., & Weinberger, D. R. (1998) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(98)80019-6 · Cited by 155
Pearlson, G. D. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200010)48:4<556::aid-ana2>3.0.co;2-2 · Cited by 150
Andersen, J. D., & Pouzet, B. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300394 · Cited by 140
Recovery of neuropsychological functions during reduction in use of phencyclidine
Cosgrove, J., & Newell, T. G. (1991) · Journal of Clinical Psychology · doi:10.1002/1097-4679(199101)47:1<159::aid-jclp2270470125>3.0.co;2-o · Cited by 139
Artaloytia, J. F., Arango, C., Lahti, A. C., Sanz, J., Pascual, A., Cubero, P., Prieto‐Merino, D., & Palomo, T. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.3.488 · Cited by 136
Fletcher, P. J., Tenn, C. C., Rizos, Z., Lovic, V., & Kapur, S. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0157-6 · Cited by 132
Idris, N. F., Repeto, P., Neill, J. C., & Large, C. H. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2058-5 · Cited by 131
Qiao, H., Noda, Y., Kamei, H., Nagai, T., Furukawa, H., Miura, H., Kayukawa, Y., Ohta, T., & Nabeshima, T. (2001) · Neuroreport · doi:10.1097/00001756-200101220-00010 · Cited by 129
Self-citationEpisodic memory and learning in patients with chronic schizophrenia
Rushe, T., Woodruff, P. W. R., Murray, R. M., & Morris, R. G. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00117-0 · Cited by 111
Harich, S., Groß, G., & Bespalov, A. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0742-y · Cited by 108
Abdul-Monim, Z., Reynolds, G. P., & Neill, J. C. (2003) · Journal of Psychopharmacology · doi:10.1177/0269881103017001700 · Cited by 108
Wang, C., McInnis, J., West, J. B., Bao, J., Anastasio, N. C., Guidry, J. A., Ye, Y., Salvemini, D., & Johnson, K. M. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041798 · Cited by 107
Mutation analysis of the NMDAR2B (GRIN2B) gene in schizophrenia
Ohtsuki, T., Sakurai, K., Dou, H., Toru, M., Yamakawa‐Kobayashi, K., & Arinami, T. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000808 · Cited by 103
Melone, M., Vitellaro‐Zuccarello, L., Vallejo‐Illarramendi, A., Pérez‐Samartín, A., Matute, C., Cozzi, A., Pellegrini-Giampietro, D. E., Rothstein, J. D., & Conti, F. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000880 · Cited by 103
Noda, Y., Kamei, H., Mamiya, T., Furukawa, H., & Nabeshima, T. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00138-x · Cited by 99
Self-citationItokawa, M., Yamada, K., Yoshitsugu, K., Toyota, T., Suga, T., Ohba, H., Watanabe, A., Hattori, E., Shimizu, H., Kumakura, T., et al. (2003) · Pharmacogenetics · doi:10.1097/00008571-200305000-00006 · Cited by 98
Mouri, A., Noda, Y., Noda, A., Nakamura, T., Tokura, T., Yura, Y., Nitta, A., Furukawa, H., & Nabeshima, T. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.032961 · Cited by 98
Self-citationProlonged psychosis attributed to phencyclidine: report of three cases
Rainey, J. M., & Crowder, M. K. (1975) · American Journal of Psychiatry · doi:10.1176/ajp.132.10.1076 · Cited by 98
Mandillo, S., Rinaldi, A., Oliverio, A., & Mele, A. (2003) · Behavioural Pharmacology · doi:10.1097/00008877-200311000-00006 · Cited by 97
Dissimilar patterns of degeneration in brain following four different addictive stimulants
Ellison, G. D., & Switzer, R. C. (1993) · Neuroreport · doi:10.1097/00001756-199310000-00004 · Cited by 93
Sircar, R. (2003) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(03)00026-1 · Cited by 81
Emamian, E. S., Karayiorgou, M., & Gogos, J. A. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4650-03.2004 · Cited by 80
Effects of repeated treatment with amphetamine or phencyclidine on working memory in the rat
Stefani, M. R., & Moghaddam, B. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00040-2 · Cited by 80
Effects of Sustained Phencyclidine Exposure on Sensorimotor Gating of Startle in Rats
Martinez, Z. A., Ellison, G. D., Geyer, M. A., & Swerdlow, N. R. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00137-7 · Cited by 77
Hajszán, T., Léránth, C., & Roth, R. H. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.015 · Cited by 75
Murai, R., Noda, Y., Matsui, K., Kamei, H., Mouri, A., Matsuba, K., Nitta, A., Furukawa, H., & Nabeshima, T. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.03.003 · Cited by 73
Self-citationNabeshima, T., Fukaya, H., Yamaguchi, K., Ishikawa, K., Furukawa, H., & Kameyama, T. (1987) · European Journal of Pharmacology · doi:10.1016/0014-2999(87)90753-9 · Cited by 69
Self-citationNoda, Y., Mamiya, T., Furukawa, H., & Nabeshima, T. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00067-8 · Cited by 64
Self-citationNoda, A., Noda, Y., Kamei, H., Ichihara, K., Mamiya, T., Nagai, T., Sugiura, S., Furukawa, H., & Nabeshima, T. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00192-5 · Cited by 63
Self-citationNabeshima, T., Yamada, K., Yamaguchi, K., Hiramatsu, M., Furukawa, H., & Kameyama, T. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90170-x · Cited by 62
Self-citationBehavioral effects of chronic phencyclidine administration in rats
Sturgeon, R. D., Fessler, R. G., London, S. F., & Meltzer, H. Y. (1982) · Psychopharmacology · doi:10.1007/bf00430755 · Cited by 62
Kitaichi, K., Yamada, K., Hasegawa, T., Furukawa, H., & NABESHIMA, T. (1994) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.66.181 · Cited by 61
Self-citationEffects of neuroleptics on phencyclidine (PCP)-induced locomotor stimulation in mice
Freed, W. J., Bing, L. A., & Wyatt, R. J. (1984) · Neuropharmacology · doi:10.1016/s0028-3908(84)80011-8 · Cited by 59
Reynolds, L. M., Cochran, S. M., MORRIS, B. J., Pratt, J. A., & Reynolds, G. P. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.02.003 · Cited by 59
Enomoto, T., Noda, Y., Mouri, A., Shin, E., Wang, D., Murai, R., Hotta, K., Furukawa, H., Nitta, A., Kim, H., et al. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.011304 · Cited by 55
Self-citationTakahashi, M., Kakita, A., Futamura, T., Watanabe, Y., Mizuno, M., Sakimura, K., Ċastrén, E., Nabeshima, T., Someya, T., & Nawa, H. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04106.x · Cited by 54
Self-citationWang, C. Z., & Johnson, K. M. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20559 · Cited by 54
Gemperle, A. Y., Enz, A., Pozza, M. F., L�thi, A., & Olpe, H. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00769-8 · Cited by 54
Nagai, T., Noda, Y., Une, T., Furukawa, K., Furukawa, H., Kan, Q., & Nabeshima, T. (2003) · Neuroreport · doi:10.1097/00001756-200302100-00023 · Cited by 52
Self-citationRice, S. R., Niu, N., Berman, D., Heston, L. L., & Sobell, J. L. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000838 · Cited by 52
The Role of Caspase-3 Activation in Phencyclidine-Induced Neuronal Death in Postnatal Rats
Wang, C. Z., & Johnson, K. M. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301202 · Cited by 50
Corbett, R. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00128-1 · Cited by 44
Li, Z., Kim, C. H., Ichikawa, J., & Meltzer, H. Y. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00085-6 · Cited by 44
Wiley, J. L., Bühler, K. G., LaVecchia, K. L., & Johnson, K. M. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00146-5 · Cited by 39
Altered NMDA Sensitivity and Learning Following Chronic Developmental NMDA Antagonism
Brooks, W. J., Weeks, A. C. W., LeBoutillier, J. C., & Petit, T. L. (1997) · Physiology & Behavior · doi:10.1016/s0031-9384(97)00169-8 · Cited by 34
Kitaichi, K., Yamada, K., Yoneda, Y., Ogita, K., Hasegawa, T., Furukawa, H., & Nabeshima, T. (1995) · Life Sciences · doi:10.1016/0024-3205(94)00482-8 · Cited by 21
Self-citationMarquis, J., Goulet, S., & Doré, F. Y. (2003) · Neurobiology of Learning and Memory · doi:10.1016/s1074-7427(03)00067-4 · Cited by 19
Rule shift under long-term PCP challenge in rats
Deschênes, A., Goulet, S., & Doré, F. Y. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.08.013 · Cited by 19
Cited by
Animal models of schizophrenia
Jones, C., Watson, D., & Fone, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01386.x · Cited by 771
Ketamine-Induced Loss of Phenotype of Fast-Spiking Interneurons Is Mediated by NADPH-Oxidase
Behrens, M. M., Ali, S. S., Dao, D. N., Lucero, J., Shekhtman, G., Quick, K. L., & Dugan, L. L. (2007) · Science · doi:10.1126/science.1148045 · Cited by 585
Schobel, S. A., Chaudhury, N. H., Khan, U. A., Paniagua, B., Styner, M. A., Asllani, I., Inbar, B. P., Corcoran, C. M., Lieberman, J. A., Moore, H., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.011 · Cited by 549
Neill, J. C., Barnes, S., Cook, S., Grayson, B., Idris, N. F., McLean, S. L., Snigdha, S., Rajagopal, L., & Harte, M. K. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.07.004 · Cited by 530
The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia
Na, K.-S., Jung, H.-Y., & Kim, Y.-K. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.10.022 · Cited by 427
Metadata
- Authors
- Mouri, A., Noda, Y., Enomoto, T., & Nabeshima, T.
- Venue
- Neurochemistry International
- Publisher
- Elsevier BV
- Published
- 2007-07
- Volume
- 51
- Issue
- 2-4
- Pages
- 173-184
- ISSN
- 0197-0186 (ISSN-L)
- OpenAlex
- W1980068687
- Cited by
- 266
- References
- 97
- FWCI
- 13.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.